Steven L Basta insider trades
Open-market stock purchases and sales by Steven L Basta, President and CEO at Phathom Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 16, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 10, 2026 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 10, 2026 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $80.5K |
| Jan 2, 2026 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 2, 2026 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 17, 2025 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 17, 2025 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $484K |
| Dec 12, 2025 | VYNE VYNE Therapeutics Inc | Bought (not open market) | — |
| Nov 28, 2025 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $756K |
| Nov 28, 2025 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- PHAT Phathom Pharmaceuticals, Inc: other filings, last Feb 10, 2026
- VYNE VYNE Therapeutics Inc: other filings, last Dec 12, 2025
- VIVE Viveve Medical, Inc: other filings, last Jan 3, 2023
- MNLO Menlo Therapeutics Inc: other filings, last Aug 3, 2020
- CBYL KalVista Pharmaceuticals, Inc: other filings, last Nov 21, 2016
- BFRM Bioform Medical Inc: other filings, last Feb 16, 2010